LONDON, 22 December 2011 – Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as nominated adviser and broker to Avacta Group plc (AIM: AVCT) on a placing to raise £5.13m.

The proceeds from the placing are to be used on activities which the directors of Avacta believe will accelerate the growth of the company, in particular driving faster growth of recurring revenue from proprietary reagents and consumables including the development of the intellectual property of Aptuscan Limited, a company being acquired by Avacta conditional upon the placing.

Avacta Group is a leading healthcare technology, reagents and consumables company providing proprietary analytical and diagnostics solutions to the life sciences/healthcare sector.